KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Equity Income: 2012-2016

Historic Equity Income for Charles River Laboratories International (CRL) over the last 5 years, with Sep 2016 value amounting to $442,000.

  • Charles River Laboratories International's Equity Income fell 86.36% to $442,000 in Q3 2016 from the same period last year, while for Sep 2016 it was $8.7 million, marking a year-over-year increase of 58.05%. This contributed to the annual value of $3.8 million for FY2015, which is 58.90% down from last year.
  • Charles River Laboratories International's Equity Income amounted to $442,000 in Q3 2016, which was down 91.15% from $5.0 million recorded in Q2 2016.
  • Over the past 5 years, Charles River Laboratories International's Equity Income peaked at $6.1 million during Q1 2014, and registered a low of -$907,000 during Q2 2015.
  • Moreover, its 3-year median value for Equity Income was $1.9 million (2014), whereas its average is $2.0 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Equity Income soared by 6,882.22% in 2014, and later slumped by 143.69% in 2015.
  • Charles River Laboratories International's Equity Income (Quarterly) stood at -$373,000 in 2012, then soared by 386.33% to $1.1 million in 2013, then surged by 80.15% to $1.9 million in 2014, then slumped by 88.62% to $219,000 in 2015, then tumbled by 86.36% to $442,000 in 2016.
  • Its Equity Income stands at $442,000 for Q3 2016, versus $5.0 million for Q2 2016 and $3.1 million for Q1 2016.